On request of Infant Bacterial Therapeutics AB (publ), company registration number 556873-8586, Nasdaq Stockholm AB has admitted the company’s B-shares to trading on Nasdaq Stockholm, with effect from September 10, 2018. The shares are currently traded on Nasdaq First North premier.
The company has 377,736 A-shares and 10,848,448 B-shares as per today’s date.
| Short Name: | IBT B |
| Number of B-shares to be listed: | 10,848,448 |
| ISIN Code: | SE0008015259 |
| Order Book ID: | 120381 |
| Average Daily Turnover: | 281,842 EUR |
| Clearing: | CCP cleared |
| Segment: | Mid Cap |
| Market segment: | STO Equities CCP / 182 |
| Tick Size Table: | MiFID II tick size table / 230 |
| MIC: | XSTO |
ICB Classification:
| Industry code: | 4000 Health Care |
| Supersector code: | 4500 Health Care |
For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 60 00, or iss@nasdaq.com.